|Bid||371.10 x 1100|
|Ask||371.23 x 1100|
|Day's Range||365.75 - 382.82|
|52 Week Range||271.56 - 398.65|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||39.21|
|Earnings Date||Apr 29, 2020 - May 03, 2020|
|Forward Dividend & Yield||1.36 (0.36%)|
|Ex-Dividend Date||Nov 13, 2019|
|1y Target Est||410.73|
Teleflex (TFX) delivered earnings and revenue surprises of 2.18% and 0.34%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
WAYNE, Pa., Feb. 20, 2020 -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per.
Fourth Quarter 2019 Revenues of $681.0 million, up 6.1% Versus Prior Year Period; up 7.1% on a Constant Currency Basis Fourth Quarter 2019 GAAP Diluted EPS from Continuing.
Teleflex's (TFX) COMFORT FLO Humidification System up for worldwide voluntary recall after the receipt of complaints of device malfunction.
Teleflex Incorporated (TFX), a global provider of medical technologies for critical care and surgery, has announced a worldwide voluntary recall of the COMFORT FLO® Humidification System. The recalled products provide a continuous flow of heated and humidified gas to COMFORT FLO® patients in professional health care environments. The recalled product can be identified by the presence of only one white reservoir clamp on the feed tube (distinguishing itself from new product which contains two blue reservoir clamps on the feed tube).
WAYNE, Pa., Feb. 13, 2020 -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 9th Annual SVB Leerink Global Healthcare Conference.
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WAYNE, Pa., Feb. 06, 2020 -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market.
Teleflex (TFX) receives the FDA clearance for its bipolar temporary pacing guidewire, thus paving the way for improvements in TAVR and BAV procedures.
Teleflex Incorporated (TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV).
Minimally Invasive UroLift® System Provides Safe and Effective Symptom Relief for Men with an Enlarged Prostate While Preserving Sexual Function* WAYNE, Pa., Jan. 14, 2020 --.
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
Teleflex (TFX) receives FDA clearance for expanded indication for the utilization of the UroLift System for treating larger prostrates in men.
Teleflex Incorporated (TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for the use of its UroLift® System to treat larger prostates, between 80cc and100cc. BPH, also known as enlarged prostate, is non-cancerous enlargement of the prostate that occurs as men age.
A Chester County aerospace supplier had the best stock performance of 2019, more than doubling its share price.
WAYNE, Pa., Jan. 02, 2020 -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 38th Annual J.P. Morgan Healthcare Conference at the.
WAYNE, Pa., Dec. 30, 2019 -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Goldman Sachs 12th Annual Healthcare CEOs.
Teleflex Incorporated (TFX), a leading global provider of medical technologies for critical care and surgery, announced that it was named the winner of MedReps.com’s 9th Annual Best Places to Work 2020 survey for the Large Category Best Medical Device Companies and came in second in the Overall Category, covering Best Medical Device Companies, Best Pharma Companies and Best Biotech Companies. “We are honored to once again be named a winner of the prestigious Best Place to Work award in medical sales,” said Liam Kelly, President and Chief Executive Officer.
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons. Nevertheless, the data show elite investors' consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat […]